Pfizer and Novartis increasing pharmaceutical distribution cost

Multinational pharmaceutical companies, such as Pfizer and Novartis which have expressed opposition to the pharmaceutical distribution cost raise, started to withdraw their previous positions due to pressure of the Korea Pharmaceutical Distribution Association(KPDA).

According to the KPDA, Novartis and Pfizer will increase distribution cost on the 1^st of October and the 1^st of December, respec...